Home » Taro Pharma Gets Final FDA Approval for Lamotrigine Chewable Tablets ANDA
Taro Pharma Gets Final FDA Approval for Lamotrigine Chewable Tablets ANDA
Taro Pharmaceutical Industries Ltd. said that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Lamotrigine Chewable Tablets, 5 mg and 25 mg.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May